Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in a Cohort of Patients Suffering From Epilepsy With Focal Onset Seizure (FOS) and Enrolled Into the Early Access Program (EAP) in Germany, France and UK

NCT05747001 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT05747001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05747001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in a Cohort of Patients Suffering From Epilepsy With Focal Onset Seizure (FOS) and Enrolled Into the Early Access Program (EAP) in Germany, France and UK
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Observational
Overall status
Completed
Start date
January 27, 2023
Completion date
September 30, 2023
Enrollment
319 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, focal onset seizure